Enhancement of in vitro bactericidal activity of neutrophils from trauma patients in the presence of granulocyte colony-stimulating factor

  • K. Anding
  • A. Kropec
  • E. Schmidt-Eisenlohr
  • A. Benzing
  • K. Geiger
  • F. Daschner


In order to determine whether granulocyte colony-stimulating factor (G-CSF) can enhance the bactericidal activity of polymorphonuclear leukocytes (PMNL) in trauma patients, PMNL obtained from severely injured patients one or two days after trauma were incubated with G-CSF andStaphylococcus aureus for different periods of time. G-CSF at a concentration of 6000 units/ml significantly improved the antibacterial activity of PMNL in trauma patients (n=10) and healthy volunteers (n=12) during the incubation period of 180 min. No difference in the bactericidal function of PMNL could be found between severely injured patients and healthy donors.


Internal Medicine Healthy Volunteer Bactericidal Activity Incubation Period Trauma Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Polk HC, George CD, Wellhausen SR, Regan MP, George CD, Cost K, Borzotta AP, Davidson PR: A systematic study of host defense processes in badly injured patients. Annals of Surgery 1986, 204: 282–299.PubMedGoogle Scholar
  2. 2.
    O'Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH, Mannick JA: Depression of cellular immunity after multiple trauma in the absence of sepsis. Journal of Trauma 1984, 24: 869–875.PubMedGoogle Scholar
  3. 3.
    Hershman MJ, Cheadle WG, George CD, Cost KM, Appel SH, Davidson PI, Pork HL: The response of immunoglobulins to infection after thermal and nonthermal injury. American Surgeon 1988, 54: 408–411.PubMedGoogle Scholar
  4. 4.
    Groopman JE, Molina JM, Scadden DT: Hematopoetic growths factors. Biology and clinical applications. New England Journal of Medicine 1989, 321: 1449–1459.PubMedGoogle Scholar
  5. 5.
    Kitagawa S, Yuo A, Souza LM, Saito M, Miura Y, Takadu F: Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by chemotactic peptide. Biochemical and Biophysical Research Communications 1987, 144: 1143–1146.CrossRefPubMedGoogle Scholar
  6. 6.
    Wang JM, Chen ZG, Colella S, Bonilla MA, Welte K, Bordignon C, Mantovani A: Chemotactic activity of recombinant human granulocyte colony-stimulating factor. Blood 1988, 72: 1456–1460.PubMedGoogle Scholar
  7. 7.
    Bassler M, Depuis W, Just HM, Daschner FD: Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations onStaphylococcus aureus andPseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes. European Journal of Clinical Microbiology & Infectious Diseases 1983, 2: 439–444.Google Scholar
  8. 8.
    Knaus WA, Draper EA, Wagner DP: Apache II: a severity of disease classification system. Critical Care Medicine 1985, 13: 818–829.PubMedGoogle Scholar
  9. 9.
    Böyum A: Isolation of mononuclear cells and granulocytes from human blood isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scandinavian Journal of Clinical and Laboratory Investigation 1968, 21, Supplement 97: 77–89.PubMedGoogle Scholar
  10. 10.
    Buffone V, Meakins JL, Christou NV: Neutrophil function in surgical patients. Archives of Surgery 1984, 119: 39–43.PubMedGoogle Scholar
  11. 11.
    Miller SE, Miller CL, Trunkey DD: The immune consequences of trauma. Surgical Clinics of North America 1982, 62: 167–181.PubMedGoogle Scholar
  12. 12.
    Christou NV, McLean APH, Meakins JL: Host defence in blunt trauma: interrelationships of kinetics of anergy and depressed neutrophil function, nutritional status, and sepsis. Journal of Trauma 1980, 20: 833–841.PubMedGoogle Scholar
  13. 13.
    Maderazo EG, Albano SD, Woronick CL, Drezner AD, Quercia R: Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients. Annals of Surgery 1983, 198: 736–742.PubMedGoogle Scholar
  14. 14.
    Bonilla MA, Gillio AP, Ruggeiro M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Welte K, Souza LM, O'Reilly RJ: Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New England Journal of Medicine 1989, 320: 1574–1580.PubMedGoogle Scholar
  15. 15.
    Roilides E, Walsh TJ, Pizzo PA, Rubin M: Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. Journal of Infectious Diseases 1991, 163: 579–583.PubMedGoogle Scholar
  16. 16.
    Polk HC, George CD, Hershman MJ, Wellhausen SR, Cheadle WG: The capacity of serum to support neutrophil phagocytosis is a vital host defence mechanism in severely injured patients. Annals of Surgery 1988, 207: 686–692.PubMedGoogle Scholar
  17. 17.
    Milatovic D: Antibiotics and phagocytosis. European Journal of Clinical Microbiology & Infectious Diseases 1983, 5: 439–444.Google Scholar
  18. 18.
    Yasuda H, Ajiki Y, Shimozato T, Kasahara M, Kawada H, Iwata M, Shimizo K: Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics againstPseudomonas aeruginosa infections in mice. Infection and Immunity 1990, 58: 2502–2509.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • K. Anding
    • 1
  • A. Kropec
    • 1
  • E. Schmidt-Eisenlohr
    • 1
  • A. Benzing
    • 2
  • K. Geiger
    • 2
  • F. Daschner
    • 1
  1. 1.Department of Environmental Medicine and Hospital EpidemiologyUniversity of FreiburgFreiburgGermany
  2. 2.Department of Anesthesiology and Intensive Care MedicineUniversity of FreiburgFreiburgGermany

Personalised recommendations